ReviewCurrent opinion in pulmonary medicine2026
Toward precision imaging in interstitial lung disease: advances in quantitative imaging and artificial intelligence.
Review in Current opinion in pulmonary medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purpose of reviewTo discuss the most recent developments in quantitative imaging and artificial intelligence (AI) applications in interstitial lung diseases (ILD). RECENT
findingsAided by technical developments in the field, AI applications in chest imaging are increasingly being investigated, with recent algorithms showing improved performance compared with earlier techniques. This review article discusses the various roles of AI in fibrotic ILD, including diagnosis, characterization, quantification, and prognostication. SUMMARY: Increasing evidence supports the utility of quantitative CT and AI algorithms in improving visual assessment, increasing sensitivity and inter-observer agreement, as well as providing prognostic stratification in patients with a broad range of ILD. Nevertheless, the routine clinical application of these tools remains limited.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.